Form 4: Globus Medical Director Wolterman Acquires Stock Options

Director Dan Wolterman of Globus Medical Inc. [GMED] acquired stock options for 15,000 shares of Class A Common Stock on January 23, 2025.

Summary

• Dan Wolterman, a director at Globus Medical Inc. (GMED), filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on January 23, 2025, where Wolterman acquired stock options.
• These options grant the right to buy 15,000 shares of Class A Common Stock at an exercise price of $92.42.
• The options vest on January 1, 2026, and expire on January 23, 2035.
• Following the transaction, Wolterman directly owns options for 15,000 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock option grants, indicating a neutral sentiment.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of stock option grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of management with shareholders.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, Globus Medical, GMED, Stock Options, Beneficial Ownership, Director, Wolterman